Hinman Alan R
Public Health Informatics Institute, Task Force for Child Survival and Development, Decatur, Georgia 30030, USA.
Am J Prev Med. 2005 Jul;29(1):71-5. doi: 10.1016/j.amepre.2005.03.005.
In 2003, the National Vaccine Advisory Committee (NVAC) formed a working group to examine recommendations related to vaccine financing contained in the 2003 Institute of Medicine report on financing immunizations, "Financing Vaccines in the 21st Century: Assuring Access and Availability." During 2003-2004, the working group conducted a series of activities leading to a meeting with stakeholders in June 2004. Based on these discussions and meetings, NVAC recommended that the Department of Health and Human Services (DHHS) not adopt the Institute of Medicine (IOM) recommendation to replace the current immunization financing system with an insurance mandate and system of subsidies and vouchers. NVAC instead proposed substantial, but incremental, changes to the current system that would go a long way toward stabilizing the financing of immunizations in the United States. The proposed changes include expanded and stable funding for the existing immunization grant program, expansion of the Vaccines for Children program, regulatory harmonization, promotion of "first dollar" insurance coverage for immunizations, and the assurance of adequate reimbursement for the administration of vaccines.
2003年,国家疫苗咨询委员会(NVAC)成立了一个工作组,以审查2003年医学研究所关于免疫接种筹资的报告《21世纪的疫苗筹资:确保可及性和可得性》中与疫苗筹资相关的建议。在2003年至2004年期间,该工作组开展了一系列活动,并于2004年6月与利益相关者举行了一次会议。基于这些讨论和会议,NVAC建议卫生与公众服务部(DHHS)不要采纳医学研究所(IOM)的建议,即用保险授权以及补贴和代金券制度取代现行的免疫接种筹资系统。相反,NVAC提议对现行系统进行重大但渐进的改革,这将大大有助于稳定美国免疫接种的筹资。提议的改革包括为现有的免疫接种补助计划提供扩大且稳定的资金、扩大儿童疫苗计划、协调监管、促进免疫接种的“首美元”保险覆盖范围,以及确保疫苗接种管理获得足够的报销。